Atlas Trials

Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Clinical trial NCT01903824 · COMPLETED

Trial details

NCT number
NCT01903824
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cognitive Impairment
Start date
2013-08-01
Primary completion
2013-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.